4//SEC Filing
Smith Rachel 4
Accession 0001144204-18-000868
CIK 0001133869other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:05 PM ET
Size
9.0 KB
Accession
0001144204-18-000868
Insider Transaction Report
Form 4
Smith Rachel
VP of Research and Development
Transactions
- Exercise/Conversion
Common Stock
2017-12-22$0.16/sh+20,748$3,320→ 20,748 total - Tax Payment
Common Stock
2017-12-22$1.48/sh−2,244$3,321→ 18,504 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-22−20,748→ 0 totalExercise: $0.16From: 2008-01-01Exp: 2018-01-01→ Common Stock (20,748 underlying)
Footnotes (2)
- [F1]On December 22, 2017, the Reporting Person exercised, via cashless exercise, stock options for 20,748 shares of Common Stock. The exercise price was $0.16 per share and the exercise was subject to the terms and conditions of a Stock Option Award which was granted on January 1, 2008 under the Company's 2006 Stock Option Plan.
- [F2]Reflects 2,244 shares withheld by the Issuer at the market price of $1.48 per share to fund the cashless exercise of 20,748 options.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001593089
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:05 PM ET
- Size
- 9.0 KB